Is a complete APYX research report available?

No complete published report is available for Apyx Medical Corporation (APYX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Apyx Medical Corporation (APYX)

NASDAQ: APYX · USD

$4.12

+0.28 (+7.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first APYX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	172.5M
Revenue (ttm)	55.9M
Net income (ttm)	-9.2M
EPS (ttm)	-$0.22
Shares out	41.9M
Volume	76,347
Beta	1.37
Price target	$6.60	+60.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55.9M
Net income (ttm): -9.2M
EPS (ttm): -$0.22
Market cap: 172.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All APYX indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000719135
Company name	Apyx Medical Corporation
Country	United States
Country code	US
Cusip	03837C106
Employees	205
Employees Change	-15%
Employees Change Percent	-6.82
Enterprise value	$180.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	38.6
Industry PE Fwd	19.63
IPO Date	1987-01-01
Isin	US03837C1062
Last refreshed	2026-07-31
Market cap	$172.5M
Market cap category	Micro-Cap
Price	$4.12
Price currency	USD
Rev Per Employee	272,702.44x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	3841
Symbol	APYX
Website	https://apyxmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.31%
EV Sales Forward	2.99x
EV/Sales	3.23x
FCF yield	-5.21%
P/B ratio	13.44x
P/S ratio	3.09x
PS Forward	2.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.7%
EBITDA Margin	-6.42%
Gross margin	63.15%
Gross Profit	$35.3M
Gross Profit Growth	21.42%
Gross Profit Growth Q	39.89%
Gross Profit Growth3 Y	7.42%
Gross Profit Growth5 Y	11.62%
Net Income	$-9.2M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-15.58%
Profit Margin	-16.4%
Profit Per Employee	$-44,727
ROA	-4.37
Roa5y	-15.67
ROCE	-8.04
ROE	-76.49
Roe5y	-65.02
ROIC	-5.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.34%
Cagr15y	3.06%
Cagr1y	110.31%
Cagr20y	-3.27%
Cagr3y	-6.56%
Cagr5y	-14.86%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	18.22x
Revenue Growth Q	32.45x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	8.18x
Revenue Growth5 Y	12.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.91
Assets	$63M
Cash	$31.1M
Current Assets	$54.8M
Current Liabilities	$9.4M
Debt	$39.5M
Debt Equity	$3.02
Equity	$13.1M
Interest Coverage	-0.77
Liabilities	$49.9M
Long Term Assets	$8.2M
Long Term Liabilities	$40.5M
Net Cash	$-8.3M
Net Cash By Market Cap	$-4.82
Net Debt Equity	$0.64
Tangible Book Value	$12.8M
Tangible Book Value Per Share	$0.31
WACC	11.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.8
Inventory Turnover	2.39
Net Working Capital	$14.7M
Quick ratio	4.65
Working Capital	$45.3M
Working Capital Turnover	$1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	122.7%
1Y total return	110.2%
200-day SMA	3.82
3Y total return	-18.42%
50-day SMA	4.22
50-day SMA vs 200-day SMA	50over200
5Y total return	-55.27%
All Time High	17.5
All Time High Change	-76.46%
All Time High Date	2021-11-22
All Time Low	0.34
All Time Low Change	1,098.37%
All Time Low Date	1999-07-13
ATR	0.28
Beta	1.37
Beta1y	0.34
Beta2y	1.85
Ch YTD	17.71
High	4.32
High52	5.08
High52 Date	2026-06-09
High52ch	-18.9%
Low	3.78
Low52	1.59
Low52 Date	2025-08-01
Low52ch	159.12%
Ma50ch	-2.42%
Price vs 200-day SMA	7.91%
RSI	49.73
RSI Monthly	57.74
RSI Weekly	54.06
Sharpe ratio	1.27x
Sortino ratio	2.36
Total Return	-12.91%
Tr YTD	17.71
Tr15y	57.25%
Tr1m	-12.15%
Tr1w	7.57%
Tr3m	19.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.09
Earnings Revenue Estimate	13,325,500x
Earnings Revenue Estimate Growth	17.17x
Operating Income	$-4.3M
Operating margin	-7.7
Price target	$6.6
Price Target Change	$60.19

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,929,771%
Float Percent	71.48%
Net Borrowing	-20,000
Shares Insiders	13.64%
Shares Institutions	36.43%
Shares Out	41,873,951
Shares Qo Q	3.74%
Shares Yo Y	12.91%
Short Float	0.84%
Short Ratio	2.31
Short Shares	0.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.9M
Adjusted OCF	-9,733,000
Average Volume	59,074.15x
Bv Per Share	0.31
CAPEX	$-1.1M
Ch10y	122.7
Ch15y	57.25
Ch1m	-12.15
Ch1w	7.57
Ch1y	110.2
Ch20y	-48.56
Ch3m	19.08
Ch3y	-18.42
Ch5y	-55.27
Ch6m	1.73
Change	7.29%
Change From Open	7.29
Close	3.84
Days Gap	0
Depreciation Amortization	719,000
Dollar Volume	314,549.6
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-4.3M
EBITDA	$-3.6M
EPS	$-0.22
F Score	4
FCF	$-9M
FCF EV Yield	-4.97x
FCF Per Share	$-0.21
Financing CF	9,638,000
Fiscal Year End	December
Founded	1,982
Income Tax	$364,000
Investing CF	-1,119,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	1994-01-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	3.88
Ma150ch	6.08%
Ma20	4.16
Ma20ch	-0.87%
Net CF	126,000
Next Earnings Date	2026-08-06
Open	3.84
Optionable	Yes
Position In Range	62.96
Post Close	4.12
Postmarket Change Percent	-3.06
Postmarket Price	$3.99
Ppne	6,349,000
Price Date	2026-07-30
Ptbv Ratio	13.44
Relative Volume	1.29x
Revenue	55,904,000x
SBC By Revenue	3.33x
Share Based Comp	1,862,000
Tax By Revenue	0.65x
Tr20y	-48.56%
Tr6m	1.73%
Us State	Florida
Volume	76,347
Z Score	0.77

Apyx Medical Corporation (APYX)

Coverage state: Market snapshot only — no published research

Generate the first APYX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · APYX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All APYX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on APYX

Frequently asked questions